ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $140,006,000 | +277.4% | 3,021,920 | +98.6% | 0.21% | +275.0% |
| Q1 2019 | $37,101,000 | -13.2% | 1,521,778 | -49.3% | 0.06% | -16.4% |
| Q4 2018 | $42,741,000 | -13.3% | 2,999,334 | -7.5% | 0.07% | +11.7% |
| Q3 2018 | $49,275,000 | +160.7% | 3,241,784 | +187.8% | 0.06% | +140.0% |
| Q2 2018 | $18,900,000 | -14.8% | 1,126,337 | -17.1% | 0.02% | -16.7% |
| Q1 2018 | $22,171,000 | -38.4% | 1,358,502 | -51.7% | 0.03% | -40.0% |
| Q4 2017 | $36,010,000 | -1.5% | 2,813,317 | -5.4% | 0.05% | -10.7% |
| Q3 2017 | $36,565,000 | -36.7% | 2,972,794 | -56.9% | 0.06% | -45.6% |
| Q2 2017 | $57,795,000 | -0.9% | 6,904,997 | +5.8% | 0.10% | -2.8% |
| Q1 2017 | $58,327,000 | +258.4% | 6,524,344 | +252.3% | 0.11% | +211.8% |
| Q4 2016 | $16,276,000 | -59.1% | 1,851,696 | -68.6% | 0.03% | -49.3% |
| Q3 2016 | $39,749,000 | +504.0% | 5,888,810 | +218.6% | 0.07% | +346.7% |
| Q2 2016 | $6,581,000 | +63.3% | 1,848,608 | +35.3% | 0.02% | +50.0% |
| Q1 2016 | $4,030,000 | -81.2% | 1,366,105 | -73.1% | 0.01% | -77.8% |
| Q4 2015 | $21,412,000 | +78.4% | 5,073,989 | +92.8% | 0.04% | +95.7% |
| Q3 2015 | $12,002,000 | +2.0% | 2,632,022 | +61.2% | 0.02% | +4.5% |
| Q2 2015 | $11,770,000 | -38.0% | 1,632,482 | -36.7% | 0.02% | -37.1% |
| Q1 2015 | $18,996,000 | +343.6% | 2,577,465 | +184.7% | 0.04% | +288.9% |
| Q4 2014 | $4,282,000 | +85.3% | 905,205 | +39.8% | 0.01% | +50.0% |
| Q3 2014 | $2,311,000 | -4.5% | 647,452 | +22.0% | 0.01% | -14.3% |
| Q2 2014 | $2,421,000 | +25.0% | 530,901 | +28.8% | 0.01% | +16.7% |
| Q1 2014 | $1,937,000 | -59.8% | 412,031 | -57.2% | 0.01% | -60.0% |
| Q4 2013 | $4,822,000 | +46.1% | 962,515 | +81.4% | 0.02% | +36.4% |
| Q3 2013 | $3,301,000 | +229.1% | 530,675 | +140.3% | 0.01% | +266.7% |
| Q2 2013 | $1,003,000 | – | 220,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |